D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 79 Citations 33,376 258 World Ranking 329 National Ranking 11
Medicine D-index 103 Citations 56,448 547 World Ranking 3318 National Ranking 96

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

His primary areas of study are Internal medicine, Immunology, Acquired immunodeficiency syndrome, Surgery and Cohort study. Peter Reiss regularly links together related areas like Gastroenterology in his Internal medicine studies. His work is dedicated to discovering how Immunology, Saquinavir are connected with Ritonavir and Pharmacotherapy and other disciplines.

His research in Acquired immunodeficiency syndrome intersects with topics in Absolute risk reduction, Epidemiology, Chemoprophylaxis, Adverse effect and Intensive care medicine. His research in the fields of Discontinuation and Asymptomatic overlaps with other disciplines such as Risk assessment. His Cohort study research is multidisciplinary, incorporating perspectives in Mortality rate and Viral load.

His most cited work include:

  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel (2345 citations)
  • Combination antiretroviral therapy and the risk of myocardial infarction (1490 citations)
  • Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. (1341 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Internal medicine, Immunology, Acquired immunodeficiency syndrome, Cohort and Viral load. His research integrates issues of Gastroenterology and Surgery in his study of Internal medicine. He works mostly in the field of Gastroenterology, limiting it down to concerns involving Nevirapine and, occasionally, Efavirenz.

His work on Viral disease, Didanosine and Virus as part of general Immunology research is frequently linked to Cart, thereby connecting diverse disciplines of science. His work deals with themes such as Interquartile range, Incidence, Demography, Hepatitis C and Comorbidity, which intersect with Cohort. His biological study deals with issues like Regimen, which deal with fields such as Reverse-transcriptase inhibitor and Pharmacology.

He most often published in these fields:

  • Internal medicine (56.66%)
  • Immunology (25.58%)
  • Acquired immunodeficiency syndrome (19.54%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (56.66%)
  • Cohort (17.41%)
  • Acquired immunodeficiency syndrome (19.54%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Cohort, Acquired immunodeficiency syndrome, Cohort study and Viral load. As part of his studies on Internal medicine, Peter Reiss often connects relevant areas like Poisson regression. The various areas that Peter Reiss examines in his Cohort study include Demography, Hepatitis C, Effects of sleep deprivation on cognitive performance, Coinfection and Comorbidity.

His Acquired immunodeficiency syndrome research is multidisciplinary, relying on both Transmission, Regimen, Absolute risk reduction and Cobra. His research in Cohort study tackles topics such as Odds ratio which are related to areas like Lopinavir. Viral load is a subfield of Immunology that he tackles.

Between 2016 and 2021, his most popular works were:

  • Increased brain-predicted aging in treated HIV disease (118 citations)
  • Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study (80 citations)
  • Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report (54 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

Peter Reiss focuses on Internal medicine, Cohort, Acquired immunodeficiency syndrome, Cohort study and Comorbidity. His Internal medicine study incorporates themes from Cognition, Poisson regression and Men who have sex with men. His study in Cohort is interdisciplinary in nature, drawing from both Epidemiology and Biomarkers of aging.

Peter Reiss interconnects Immunodeficiency, Virology, Immunology and Cobra in the investigation of issues within Acquired immunodeficiency syndrome. His Cohort study research is multidisciplinary, incorporating perspectives in Relative risk, Regimen, Demography and Cause of death. His research integrates issues of Hepatitis B, Prospective cohort study, Adverse effect and Survival analysis in his study of Incidence.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Combination antiretroviral therapy and the risk of myocardial infarction

Nina Friis-Møller;Caroline A Sabin;Rainer Weber;Antonella d'Arminio Monforte.
The New England Journal of Medicine (2003)

2383 Citations

Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy.
JAMA (2008)

2345 Citations

Class of antiretroviral drugs and the risk of myocardial infarction.

Nina Friis-Moller;Peter Reiss;Caroline A. Sabin;Rainer Weber.
The New England Journal of Medicine (2007)

2026 Citations

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips.
The Lancet (2002)

1977 Citations

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

A Mocroft;B Ledergerber;C Katlama;O Kirk.
The Lancet (2003)

1550 Citations

Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study

Rainer Weber;Caroline A Sabin;Nina Friis-Møller;Peter Reiss.
JAMA Internal Medicine (2006)

1394 Citations

Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study

Nina Friis-Møller;Rainer Weber;Peter Reiss;Rodolphe Thiebaut.
AIDS (2003)

1302 Citations

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

Caroline Sabin;Signe Westring Worm;Rainer Weber.
The Lancet (2008)

1063 Citations

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

Kees Brinkman;Jan A Smeitink;Johannes A Romijn;Peter Reiss.
The Lancet (1999)

1058 Citations

A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients: The INCAS Trial

Julio S. G. Montaner;Peter Reiss;David Cooper;Stefano Vella.
JAMA (1998)

974 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Peter Reiss

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 241

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 205

Amy C. Justice

Amy C. Justice

Yale University

Publications: 197

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 193

Dominique Costagliola

Dominique Costagliola

Université Paris Cité

Publications: 172

Manuel Battegay

Manuel Battegay

University Hospital of Basel

Publications: 153

Vincent Soriano

Vincent Soriano

Hospital Universitario La Paz

Publications: 150

Richard D. Moore

Richard D. Moore

Johns Hopkins University

Publications: 148

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 146

David A. Cooper

David A. Cooper

Pfizer (United States)

Publications: 145

Caroline Sabin

Caroline Sabin

University College London

Publications: 142

Enos Bernasconi

Enos Bernasconi

Universita della Svizzera Italiana

Publications: 133

Matthias Egger

Matthias Egger

University of Bern

Publications: 129

Matthias Cavassini

Matthias Cavassini

University of Lausanne

Publications: 126

Hansjakob Furrer

Hansjakob Furrer

University of Bern

Publications: 126

Amanda Mocroft

Amanda Mocroft

University College London

Publications: 123

Trending Scientists

Lutz Tobiska

Lutz Tobiska

Otto-von-Guericke University Magdeburg

Toshiyuki Momma

Toshiyuki Momma

Waseda University

Akira Shirakawa

Akira Shirakawa

University of Electro-Communications

Masa-aki Haga

Masa-aki Haga

Chuo University

Henry Houlden

Henry Houlden

University College London

Juan Carlos Izpisua Belmonte

Juan Carlos Izpisua Belmonte

Salk Institute for Biological Studies

David C. White

David C. White

University of Tennessee at Knoxville

Philipp A. Lang

Philipp A. Lang

Heinrich Heine University Düsseldorf

Jay A. Fishman

Jay A. Fishman

Harvard University

Alexandre Schubnel

Alexandre Schubnel

École Normale Supérieure

Sebastian Sobek

Sebastian Sobek

Uppsala University

Rucong Yu

Rucong Yu

China Meteorological Administration

Erin A. Hazlett

Erin A. Hazlett

Icahn School of Medicine at Mount Sinai

Sasithon Pukrittayakamee

Sasithon Pukrittayakamee

Mahidol University

Peter J. Allen

Peter J. Allen

Duke University

Deirdre Curtin

Deirdre Curtin

European University Institute

Something went wrong. Please try again later.